作者
Ahmad Tavakoli, Angila Ataei-Pirkooh, Gity Mm Sadeghi, Farah Bokharaei-Salim, Peyman Sahrapour, Seyed J Kiani, Mohsen Moghoofei, Mohammad Farahmand, Davod Javanmard, Seyed H Monavari
发表日期
2018/10/22
期刊
Nanomedicine
卷号
13
期号
21
页码范围
2675-2690
出版商
Future Medicine Ltd
简介
Aim
We aimed to determine the possible inhibitory effects of zinc oxide nanoparticles (ZnO–NPs) and polyethylene glycol (PEG)-coated ZnO–NPs (ZnO–PEG–NPs) on herpes simplex virus type 1 (HSV-1).
Materials & methods
PEGylated ZnO–NPs were synthesized by the mechanical method. Antiviral activity was assessed by 50% tissue culture infectious dose (TCID50) and real-time PCR assays. To confirm the antiviral activity of ZnO–NPs on expression of HSV-1 antigens, indirect immunofluorescence assay was also conducted.
Results
200 μg/ml ZnO–PEG–NPs could result in 2.5 log10 TCID50 reduction in virus titer, with inhibition rate of approximately 92% in copy number of HSV-1 genomic DNA.
Conclusion
ZnO–PEG–NPs could be proposed as a new agent for efficient HSV-1 inhibition. Our results indicated that PEGylation is effective in reducing cytotoxicity and increasing antiviral activity …
引用总数
2019202020212022202320241203238348